ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1711

Association of Vascular Calcification and Perivascular Adipose Tissue of the Descending Aorta with Cardiovascular Events in SLE

Kelly J. Shields1, Emma Barinas-Mitchell2, Amy H. Kao3, Susan Manzi4 and Kim Sutton-Tyrrell2, 1Medicine, Lupus Center of Excellence / Allegheny Health Network, Pittsburgh, PA, 2Epidemiology, University of Pittsburgh, Pittsburgh, PA, 3Lupus Center of Excellence, Allegheny Singer Research Institute, Pittsburgh, PA, 4Division of Rheumatology, University of Pittsburgh School of Medicine, Pittsburgh, PA

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: cardiovascular disease and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Lupus Erythematosus - Clinical Aspects and Treatment III: Cardiovascular

Session Type: Abstract Submissions (ACR)

Background/Purpose: Women with systemic lupus erythematosus (SLE) have an increased risk of cardiovascular disease (CVD).  We have shown that clinically CVD-free women with SLE have an increased volume of descending aortic perivascular adipose tissue (aPVAT).  This small adipose depot was also associated with aortic calcification (AC) independent of overall adiposity.  Thus, we hypothesized that clinically CVD-free women with SLE increased aPVAT volume and premature vascular calcification measured by AC and coronary artery calcification (CAC) will predict cardiovascular events.(CVE)

Methods: Women participating in the “Heart Effects on Atherosclerosis and Risk of Thrombosis in SLE” (HEARTS) study were clinically CVD-free and diagnosed with SLE for at least 2 years.  CAC/AC were measured using electron beam computed tomography (EBCT) and quantified by Agaston scoring.  The aPVAT was quantified using commercially available software and standard attenuations values for adipose tissue (–190 to –30 HU).  Participants were followed for incident CVE confirmed by a physician. (SLE without CVE, n=128; SLE with CVE n=28).  CVE included myocardial infarction, congestive heart failure, stroke, transient ischemic attack, angina, blood clot, percutaneous coronary intervention, and catherization.

Results: Twenty eight participants (17%) experienced a first CVE within 4.6 +/- 12 months (Mean +/- SD) with three participants having multiple CVE. There were no differences in surrogate adiposity measures such as waist-to-hip ratio (p=0.58) or BMI (p=0.23) by CVE status suggesting similar adipose distribution. Traditional CVD risk factors such as age (p=0.008), systolic blood pressure (p=0.0053), pulse pressure (p=0.0047), hypertensive status (p=0.0039), CRP (p=0.0081) and homocysteine levels (p=0.017) were all significantly greater in SLE women with CVE.  The SLE women with CVE were more likely to have AC (p=0.0052).  There were no differences in CAC (p=0.21) or aPVAT (p=0.17) between SLE groups with and without CVE.  Aortic PVAT was associated with adiposity measures such as BMI (rs=0.515,p<0.0001), waist-to-hip ratio (rs=0.332,p=0.0001), and circulating inflammatory markers such as CRP (rs=0.393,p<0.0001).    In univariate models using Cox proportional-hazards regression, CAC (Hazard ratio/HR [95%CI]: 2.43 [1.1-5.5], p=0.03) was a predictor of first CVE, but AC (p=0.74) and aPVAT (p=0.20) were not predictors.  In the multivariable Cox regression models, age per 5 years (HR 1.61 [1.3-2.1], p=0.0001) and CRP (HR 1.10 [1.0-1.2], p=0.0055) remained predictors of first CVE. 

Conclusion:   Traditional CVD risk factors were independent predictors of first CVE in women with SLE in this study.  The clinically CVD free SLE women experiencing a CVE were more likely to have hypertension along with AC indicating premature vascular dysfunction.  CAC was an independent predictor of first CVE emphasizing the significant influence of calcification in this vascular bed.  Aortic PVAT was found to be significantly associated with traditional CVD risk factors, but not found to be predictive of first CVE.  Considering our previous findings, aPVAT and AC may be considered precursors to measurable subclinical CAC.


Disclosure:

K. J. Shields,
None;

E. Barinas-Mitchell,
None;

A. H. Kao,

NIH K23,

2;

S. Manzi,

Bristol Meyers Squibb Company,

9,

Exagen, Inc.,

9,

Human Genome Scieces,

9,

UCB S.A,

2,

Human Genome Sciences, Inc.,

2;

K. Sutton-Tyrrell,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/association-of-vascular-calcification-and-perivascular-adipose-tissue-of-the-descending-aorta-with-cardiovascular-events-in-sle/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology